Bio-Rad Laboratories, Inc. logo BIO - Bio-Rad Laboratories, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 7
HOLD 6
SELL 0
STRONG
SELL
0
| PRICE TARGET: $321.67 DETAILS
HIGH: $335.00
LOW: $310.00
MEDIAN: $320.00
CONSENSUS: $321.67
UPSIDE: 11.79%

About Bio-Rad Laboratories, Inc. (https://www.bio-rad.com)

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Key Executives

NAME TITLE DOB SALARY
Norman D. Schwartz Chairman & Chief Executive Officer 1950 $1,680,292 USD
Jonathan DiVincenzo President & Chief Operating Officer 1966 $1,172,954 USD
James J. Barry Executive Vice President & President of Life Science Group 1978 $1,106,516 USD
Roop K. Lakkaraju Executive Vice President & Chief Financial Officer 1971 $984,424 USD
Michael Crowley Executive Vice President of Global Commercial Operations 1962 $649,798 USD
Rajat Mehta Executive Vice President of Global Commercial Operations 1979 $649,798 USD
Anette Engelhardt Executive Vice President & President of the Clinical Diagnostics Group $401,446 USD
Courtney C. Enloe Executive Vice President, General Counsel & Secretary 1972
Erik Molitor Senior Vice President of Global Technology & Systems
Lee Boyd Senior Vice President of Global Commercial Operations - Asia Pacific
Matthew Werner Senior Vice President and Chief Compliance & Privacy Officer
Nanditha R. Yelamanchi Executive Vice President of Global Human Resources
Ruben Argueta Vice President of Investor Relations
Yong Chung Vice President of Investor Relations

Company Peers

Peer analysis pending, check back in 1-2 minutes.